Not Applicable
Not Applicable
1. Field of the Invention
In some embodiments this invention relates to implantable medical devices, their manufacture, and methods of use. Some embodiments are directed to delivery systems, such as catheter systems of all types, which are utilized in the delivery of such devices.
2. Description of the Related Art
A stent is a medical device introduced to a body lumen and is well known in the art. Typically, a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called “minimally invasive techniques” in which the stent in a radially reduced configuration, optionally restrained in a radially compressed configuration by a sheath and/or catheter, is delivered by a stent delivery system or “introducer” to the site where it is required. The introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means.
Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc. Stents may be used to reinforce body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids.
Within the vasculature, it is not uncommon for stenoses to form at a vessel bifurcation. A bifurcation is an area of the vasculature or other portion of the body where a first (or parent) vessel is bifurcated into two or more branch vessels. Where a stenotic lesion or lesions form at such a bifurcation, the lesion(s) can affect only one of the vessels (i.e., either of the branch vessels or the parent vessel) two of the vessels, or all three vessels. Many prior art stents however are not wholly satisfactory for use where the site of desired application of the stent is juxtaposed or extends across a bifurcation in an artery or vein such, for example, as the bifurcation in the mammalian aortic artery into the common iliac arteries.
The art referred to and/or described above is not intended to constitute an admission that any patent, publication or other information referred to herein is “prior art” with respect to this invention. In addition, this section should not be construed to mean that a search has been made or that no other pertinent information as defined in 37 C.F.R. §1.56(a) exists.
All US patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.
Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.
A brief abstract of the technical disclosure in the specification is provided as well only for the purposes of complying with 37 C.F.R. 1.72. The abstract is not intended to be used for interpreting the scope of the claims.
All U.S. patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.
This invention contemplates a number of embodiments where any one, any combination of some, or all of the embodiments can be incorporated into a stent and/or a stent delivery system and/or a method of use. In the context of these embodiments, the term telescoping means to extend away from a stent wall in a direction different from that of the longitudinal axis of a stent. Telescoping includes but is not limited each or any combination of: extending along a linear, varied, or curved path; extending at an oblique angle from the longitudinal axis of the stent; as well as extending along a path parallel to the longitudinal axis of the stent.
At least one embodiment of the invention is directed to a bifurcated stent being expandable from an unexpanded state to an expanded state, with a diameter smaller in the unexpanded state having a substantially tubular primary body defining a primary circumferential plane, a primary outer surface, a primary lumen and having a primary longitudinal axis extending therethrough; and a side branch assembly engaged to the primary body having at least one ring member, which is positioned substantially within the primary circumferential plane in the unexpanded state and defining a secondary circumferential plane, a secondary lumen, and having a secondary longitudinal axis extending therethrough, in the expanded state. The secondary lumen is in fluid communication with the primary lumen and forms an oblique angle with the primary longitudinal axis.
At least one embodiment of the invention is directed to a stent containing a bifurcation branch formed out of at least one ring connected to the stent. When deployed, this stent bridges vessel bifurcations by telescoping and aligning at least one ring into the vessel bifurcation. This bifurcation branch is an additional stent channel forking away from the first channel defined by the main body of the stent. The bifurcation branch is in fluid communication with the first channel and is formed by one or more rings in fluid communication with the main stent body. The rings are connected to the stent and (if there is more than one ring) to each other by connectors. In some embodiments, a telescoping ring bifurcation branch is configured to extend farther than a petal shaped stent bifurcation branch.
At least one embodiment of the invention is directed to a stent containing a bifurcation branch of two or more interconnected rings in fluid communication with the main stent body in which at least one ring is in an unextended state when the branch is not telescoped. When the branch is telescoped, the unextended ring(s) assume an extended state.
At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which the ring-ring or ring-stent connectors have a first length when the branch is untelescoped and a second length when the stent is telescoped. These different connector lengths allow for the rings to have a low profile when untelescoped and to allow for the rings to form a bifurcation branch of a large length when telescoped. This embodiment encompasses but is not limited to any stent connector known to people of ordinary skill in the art which has a longer length when expanded than when unexpanded.
At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which the ring-ring or ring-stent connectors have a bent structure when untelescoped that substantially straightens when telescoped.
At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which a ring-ring or ring-stent connectors is a flexible sinusoidal connector
At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which a ring-ring or ring-stent connector is a pivot mechanism whose rotational motion changes the distance spanned by the connector.
At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which a ring-ring or ring-stent connector is a spring whose extension changes the distance spanned by the connector.
At least one embodiment of the invention is directed to a stent containing a bifurcation branch of two or more interconnected rings where when the branch is untelescoped, the rings are in an unexpanded state and are positioned concentrically adjacent to each other within or adjacent to the circumferential plane of the ring directly connected to the main stent body.
At least one embodiment of the invention is directed to a stent containing a bifurcation branch of at least one ring which has the configuration of an at least a partially self overlapping loop when unextended and contains a self extending mechanism. This mechanism expands the rings by removing the loop overlap when forming a stent bifurcation branch.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch containing a current detachment mechanism. In this embodiment, a locking mechanism restrains the telescoping and/or the ring extension from expanding until an electrical current is applied. Once applied, the current causes the mechanism to detach from the rings allowing the rings to expand and/or to telescope and form a bifurcation branch.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which a ring may extend until either a pre-defined circumference is reached or until the extension is blocked by an anatomical feature.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which a ring contains a ratchet configuration which allows it to either increase or decrease its circumference by moving a locking mechanism along a ring's perimeter in one direction. Because the ratchet configuration prevents the locking mechanism from moving in the reverse direction, it prevents any change in circumference size in the opposite direction.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which a ring or connector is made out of metal(s), polymer(s), and/or combinations thereof.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the ring bifurcation is fed into the side body vessel by a support wire.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which when the final shape of the bifurcation branch is assumed, the branch is locked into place with a single or multiple tongue and grove latch mechanism.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the branch is formed before the stent is expanded.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the branch is formed after the stent is expanded.
At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the branch is formed at substantially the same time that the stent is expanded.
This invention also encompasses embodiments where at least one ring member has an unexpanded circumference in the unexpanded state and an expanded circumference in the expanded state, wherein the expanded circumference is greater than the unexpanded circumference, where adjacent ring members are engaged one to the other by at least one connector, and where at least one connector has a first end, a second end and a length therebetween, each end being flexibly engaged to one of the rings.
This invention also encompasses embodiments where in the unexpanded state the plurality of rings are concentrically arranged relative to one another, where in the unexpanded state the ring members are positioned laterally adjacent to one another, where at least one of the expanded state and the unexpanded state at least two ring members have differing circumferences, and where the secondary lumen comprises a length and a diameter, the diameter tapering along at least a portion of the length.
This invention also encompasses embodiments where at least one connector comprises a polymeric sheath, where the polymeric sheath is at least partially constructed out of PTFE, where at least one ring member comprises a ratchet mechanism, in the expanded state the ratchet mechanism preventing the expanded circumference from reverting to a circumference smaller than the expanded circumference, where at least one ring member is constructed and arrange to self expand from the unexpanded circumference to the expanded circumference, where at least one ring member is engaged to the primary body by at least one engagement region, the at least one engagement region having an engaged state and a released state, in the engaged state the at least one ring member being retained in the unexpanded state and in the released state the at least one ring member being released to expand to the expanded state.
At least one embodiment of the invention is directed to a stent delivery system having an unexpanded state and an expanded state, a catheter having an elongated shaft connected to a distal end; and a stent, the stent having a generally tubular main body, the main body having a diameter, the main body defining an interior, a side branch opening, and a side branch assembly adjacent to the side branch opening, the side branch assembly comprising at least one ring, there being a distance between the main body and the at least one ring, in the unexpanded state the diameter of the main body being less than the diameter of the main body in the expanded state, in the unexpanded state the distance being less than the distance in the expanded state; wherein the in the unexpanded state, the stent is disposed the distal end of the catheter.
The invention is best understood from the following detailed description when read in connection with accompanying drawings, in which:
The invention will next be illustrated with reference to the figures wherein the same numbers indicate similar elements in all figures. Such figures are intended to be illustrative rather than limiting and are included herewith to facilitate the explanation of the apparatus of the present invention.
For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.
Depicted in the figures are various aspects of the invention. Elements depicted in one figure may be combined with, or substituted for, elements depicted in another figure as desired.
Referring now to
Side branch assembly 40 in
Although
This invention encompasses a number of mechanisms for extending the ring members 41. One mechanism involves constructing the ring members to be biased towards naturally extending and then blocking this extension with a releasable restraint. One mechanism for releasing the restraint is by locating the restraint at the engagement region 93 and connecting it to a current detachment mechanism which will release the restraint when an electrical current is received. Similarly the side branch assembly 40 can also be constructed biased to telescope naturally and be held back by a releasable restraint.
One method of releasing a biased stent 10 and/or side branch assembly 40 is to remove a restraining sheath from the stent when ready for deployment. Another method is to use a current detachment mechanism that will release a restraint and allow the ring members 41 to extend upon the receipt of an electrical current which degrades the integrity of a portion of the restraint. Current detachment mechanisms which are suitable for use in the present application may be similar to such mechanism that are known to be used in the deployment of GDC coils. Examples of such mechanisms are shown and described in U.S. Pat. Nos. 5,578,074, 5,669,905, 5,984,929, and 6,579,308; the entire contents of each being incorporated herein by reference.
In some embodiment specially shaped balloons or the use of two or more balloons can be used to extend ring members or to telescope the side branch assembly 40.
Referring now to
This deployment can be accomplished by one or multiple balloons, self expansion, or by any other commonly known mechanism. The side branch assembly 40 can be telescoped before, after, or at substantially the same time that the ring members themselves are extended, and telescoping can occur before, after, or at substantially the same time as the expansion of the primary stent body 10. The ring bifurcation branch can also be telescoped by being fed into the side branch vessel 30 by guide wire 73 (not shown). Once in place, the separate guide wire 73 could have a separate locking mechanism to keep the rings in place. In this illustration all but one of the ring members 41 are extended to a larger circumference than they possessed when untelescoped. As mentioned before, all the ring members 41 need not be of differing circumferences or sizes before telescoping and this invention encompasses devices where any of the ring members 41 are designed to keep constant, increase, or decrease their circumference when telescoped. The side branch assembly 40 projects into the second vessel lumen 30 along a second longitudinal axis 2 which forms an angle with the primary longitudinal axis 1 and can be bent, curved, straight, or posses any number of configurations. The design of the side branch assembly 40 allows for the design of longer side branches branch than can be easily designed with petal type stent configurations.
In this illustration, the ring-ring connectors 43 are longer than they were when the bifurcation branch was untelescoped. This invention contemplates embodiments in which the ring-ring 43 and the ring-stent 42 connectors can also have particular characteristics to facilitate telescoping of the side branch assembly 40. These characteristics include: increasing connector lengths by using one or any combination of commonly known stent connector structures including S shaped connectors, bent connectors, flexible sinusoidal connectors, spring shaped connectors; bending and stretching connectors by constructing them out of flexible or expandable materials, spring shaped connectors, straightening curved connectors; and facilitating connector movement by including pivot mechanisms or engaging the connectors to the ring members or primary stent body by rotating loops or rings. Connector rotation can also facilitate increasing the ring-ring distance.
Referring now to
There are a number of possible mechanisms that can be used to lock an extended ring member into its final configuration and to assure that the ring member only extends (or contracts) in the desired direction and does not assume an undesired circumference. One of these mechanisms, illustrated in
A side branch assembly 40 with this locking mechanism is illustrated in
Now referring to
There are a number of additional possible embodiments of the expandable ring member 41 with a single tongue groove locking mechanism. In one possible embodiment (as illustrated in
Now referring to
Referring now to
Referring now to
In some embodiments the stent, its delivery system, or other portion of an assembly may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent and/or adjacent assembly is at least partially radiopaque. In some embodiments the delivery system of the side deployment mechanism includes balloon inflation, self expansion, and guide wire pushing or pulling.
In some embodiments at least a portion of the stent is configured to include one or more mechanisms for the delivery of a therapeutic agent. Often the agent will be in the form of a coating or other layer (or layers) of material placed on a surface region of the stent, which is adapted to be released at the site of the stent's implantation or areas adjacent thereto.
A therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc. Some examples of suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc. Where an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc. Where a therapeutic agent includes cellular material, the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof. Where the therapeutic agent includes a polymer agent, the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
This completes the description of the preferred and alternate embodiments of the invention. The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. The various elements shown in the individual figures and described above may be combined, substituted, or modified for combination as desired. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”.
Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claims below.
Number | Name | Date | Kind |
---|---|---|---|
1596754 | Moschelle | Aug 1926 | A |
1861769 | Wappler | Jun 1932 | A |
2845959 | Sidebotham | Aug 1958 | A |
3872893 | Roberts | Mar 1975 | A |
4309994 | Grunwald | Jan 1982 | A |
4410476 | Redding et al. | Oct 1983 | A |
4413989 | Schjeldahl et al. | Nov 1983 | A |
4421810 | Rasmussen | Dec 1983 | A |
4454887 | Kruger | Jun 1984 | A |
4552554 | Gould et al. | Nov 1985 | A |
4681570 | Dalton | Jul 1987 | A |
4689174 | Lupke | Aug 1987 | A |
4730616 | Frisbie et al. | Mar 1988 | A |
4769005 | Ginsburg et al. | Sep 1988 | A |
4774949 | Fogarty | Oct 1988 | A |
4896670 | Crittenden | Jan 1990 | A |
4900314 | Quackenbush | Feb 1990 | A |
4905667 | Foerster et al. | Mar 1990 | A |
4957508 | Kaneko et al. | Sep 1990 | A |
4983166 | Yamawaki | Jan 1991 | A |
4994071 | Gregor | Feb 1991 | A |
5054501 | Chuttani et al. | Oct 1991 | A |
5122125 | Deuss | Jun 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5156620 | Pigott | Oct 1992 | A |
5217440 | Frassica | Jun 1993 | A |
5219355 | Parodi et al. | Jun 1993 | A |
5244619 | Burnham | Sep 1993 | A |
5320605 | Sahota | Jun 1994 | A |
5337733 | Bauerfeind et al. | Aug 1994 | A |
5342387 | Summers | Aug 1994 | A |
5350395 | Yock | Sep 1994 | A |
5387235 | Chuter | Feb 1995 | A |
5404887 | Prather | Apr 1995 | A |
5417208 | Winkler | May 1995 | A |
5443497 | Venbrux | Aug 1995 | A |
5445624 | Jimenez | Aug 1995 | A |
5456712 | Maginot | Oct 1995 | A |
5458605 | Klemm | Oct 1995 | A |
5476471 | Shifrin et al. | Dec 1995 | A |
5487730 | Marcadis et al. | Jan 1996 | A |
5489271 | Andersen | Feb 1996 | A |
5496292 | Burnham | Mar 1996 | A |
5575771 | Walinsky | Nov 1996 | A |
5578074 | Mirigian | Nov 1996 | A |
5591228 | Edoga | Jan 1997 | A |
5599300 | Weaver et al. | Feb 1997 | A |
5607444 | Lam et al. | Mar 1997 | A |
5609605 | Marshall et al. | Mar 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5613980 | Chauhan | Mar 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5618299 | Khosravi et al. | Apr 1997 | A |
5632762 | Myler | May 1997 | A |
5632763 | Glastra | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5636641 | Fariabi | Jun 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5669905 | Scheldrup | Sep 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5669932 | Fischell et al. | Sep 1997 | A |
5672153 | Lax et al. | Sep 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5683450 | Goicoechea et al. | Nov 1997 | A |
5693086 | Goicoechea et al. | Dec 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5707348 | Krogh | Jan 1998 | A |
5709713 | Evans et al. | Jan 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5735872 | Carpenter et al. | Apr 1998 | A |
5749825 | Fischell et al. | May 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5755735 | Richter et al. | May 1998 | A |
5755770 | Ravenscroft | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5755772 | Evans et al. | May 1998 | A |
5755773 | Evans et al. | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5776101 | Goy | Jul 1998 | A |
5782906 | Marshall et al. | Jul 1998 | A |
5797951 | Mueller | Aug 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5800520 | Fogarty et al. | Sep 1998 | A |
5824036 | Lauterjung | Oct 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5827320 | Richter et al. | Oct 1998 | A |
5851464 | Davila et al. | Dec 1998 | A |
5855600 | Alt | Jan 1999 | A |
5868777 | Lam | Feb 1999 | A |
5893887 | Jayaraman | Apr 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5916263 | Goicoechea et al. | Jun 1999 | A |
5921995 | Kleshinski | Jul 1999 | A |
5938696 | Goicoechea et al. | Aug 1999 | A |
5961490 | Adams | Oct 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5968089 | Krajicek | Oct 1999 | A |
5972017 | Berg et al. | Oct 1999 | A |
5984929 | Bashiri | Nov 1999 | A |
5984955 | Wisselink | Nov 1999 | A |
5993481 | Marcade et al. | Nov 1999 | A |
6013054 | Jiun Yan | Jan 2000 | A |
6013091 | Ley et al. | Jan 2000 | A |
6016810 | Ravenscroft | Jan 2000 | A |
6017324 | Tu et al. | Jan 2000 | A |
6017363 | Hojeibane | Jan 2000 | A |
6030414 | Taheri | Feb 2000 | A |
6033433 | Her | Mar 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6039758 | Quiachon et al. | Mar 2000 | A |
6045557 | White et al. | Apr 2000 | A |
6048360 | Khosravi et al. | Apr 2000 | A |
6048361 | Von Gepen | Apr 2000 | A |
6051020 | Goicoechea et al. | Apr 2000 | A |
6056722 | Jayaraman | May 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6059824 | Taheri | May 2000 | A |
6068655 | Seguin et al. | May 2000 | A |
6071298 | Lashinski et al. | Jun 2000 | A |
6086611 | Duffy et al. | Jul 2000 | A |
6090133 | Richter et al. | Jul 2000 | A |
6093203 | Uflacker | Jul 2000 | A |
6096073 | Webster et al. | Aug 2000 | A |
6099497 | Adams et al. | Aug 2000 | A |
6099558 | White | Aug 2000 | A |
6099560 | Penn et al. | Aug 2000 | A |
6102938 | Evans et al. | Aug 2000 | A |
6113579 | Eidenschink | Sep 2000 | A |
6117117 | Mauch | Sep 2000 | A |
6117156 | Richter et al. | Sep 2000 | A |
6129738 | Lashinski et al. | Oct 2000 | A |
6129754 | Kanesaka | Oct 2000 | A |
6132459 | Piplani et al. | Oct 2000 | A |
6142973 | Carleton et al. | Nov 2000 | A |
6143002 | Vietmeier | Nov 2000 | A |
6159238 | Killion et al. | Dec 2000 | A |
6165195 | Wilson et al. | Dec 2000 | A |
6165213 | Goicoechea et al. | Dec 2000 | A |
6168621 | Vrba | Jan 2001 | B1 |
6183509 | Dibie | Feb 2001 | B1 |
6197046 | Piplani et al. | Mar 2001 | B1 |
6197049 | Shaolian et al. | Mar 2001 | B1 |
6203568 | Lombardi et al. | Mar 2001 | B1 |
6210380 | Mauch | Apr 2001 | B1 |
6210429 | Vardi | Apr 2001 | B1 |
6210431 | Power | Apr 2001 | B1 |
6210433 | Larre | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6221080 | Power | Apr 2001 | B1 |
6221090 | Wilson | Apr 2001 | B1 |
6221098 | Wilson et al. | Apr 2001 | B1 |
6231563 | White et al. | May 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6238430 | Klumb et al. | May 2001 | B1 |
6248122 | Klumb et al. | Jun 2001 | B1 |
6251133 | Richter et al. | Jun 2001 | B1 |
6254593 | Wilson | Jul 2001 | B1 |
6258073 | Mauch | Jul 2001 | B1 |
6258115 | Dubrul | Jul 2001 | B1 |
6258116 | Hojeibane | Jul 2001 | B1 |
6261273 | Ruiz | Jul 2001 | B1 |
6261305 | Marotta et al. | Jul 2001 | B1 |
6261316 | Shaolian et al. | Jul 2001 | B1 |
6264662 | Lauterjung | Jul 2001 | B1 |
6264686 | Rieu et al. | Jul 2001 | B1 |
6273909 | Kugler et al. | Aug 2001 | B1 |
6287277 | Yan | Sep 2001 | B1 |
6290673 | Shanley | Sep 2001 | B1 |
6293968 | Taheri | Sep 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6302908 | Parodi | Oct 2001 | B1 |
6306164 | Kujawski | Oct 2001 | B1 |
6312461 | Unsworth et al. | Nov 2001 | B1 |
6319278 | Quinn et al. | Nov 2001 | B1 |
6322587 | Quiachon et al. | Nov 2001 | B1 |
6325819 | Pavcnik et al. | Dec 2001 | B1 |
6325822 | Chouinard et al. | Dec 2001 | B1 |
6325826 | Vardi | Dec 2001 | B1 |
6334864 | Amplatz et al. | Jan 2002 | B1 |
6334870 | Ehr | Jan 2002 | B1 |
6346089 | Dibie | Feb 2002 | B1 |
6355060 | Lenker et al. | Mar 2002 | B1 |
6361544 | Wilson et al. | Mar 2002 | B1 |
6361555 | Wilson | Mar 2002 | B1 |
6383213 | Wilson et al. | May 2002 | B2 |
6387120 | Wilson et al. | May 2002 | B2 |
6395018 | Castaneda | May 2002 | B1 |
6436104 | Hojeibane | Aug 2002 | B2 |
6436134 | Richter | Aug 2002 | B2 |
6468301 | Amplatz et al. | Oct 2002 | B1 |
6508836 | Wilson et al. | Jan 2003 | B2 |
6514228 | Hamilton | Feb 2003 | B1 |
6517515 | Eidenschink | Feb 2003 | B1 |
6517558 | Gittings et al. | Feb 2003 | B2 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6537284 | Priddy | Mar 2003 | B1 |
6540779 | Richter et al. | Apr 2003 | B2 |
6579308 | Jansen | Jun 2003 | B1 |
6579309 | Loos | Jun 2003 | B1 |
6579312 | Wilson et al. | Jun 2003 | B2 |
6582394 | Reiss | Jun 2003 | B1 |
6596020 | Vardi et al. | Jul 2003 | B2 |
6599315 | Wilson | Jul 2003 | B2 |
6599316 | Vardi | Jul 2003 | B2 |
6645242 | Quinn | Nov 2003 | B1 |
6689156 | Davidson et al. | Feb 2004 | B1 |
6692483 | Vardi et al. | Feb 2004 | B2 |
6694877 | Brucker | Feb 2004 | B1 |
6695877 | Brucker et al. | Feb 2004 | B2 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6749628 | Callol et al. | Jun 2004 | B1 |
6776793 | Brown et al. | Aug 2004 | B2 |
6811566 | Penn et al. | Nov 2004 | B1 |
6835203 | Vardi | Dec 2004 | B1 |
6858038 | Heuser | Feb 2005 | B2 |
6884258 | Vardi et al. | Apr 2005 | B2 |
6896699 | Wilson et al. | May 2005 | B2 |
6932837 | Amplatz et al. | Aug 2005 | B2 |
6955687 | Richter et al. | Oct 2005 | B2 |
6955688 | Wilson et al. | Oct 2005 | B2 |
6962602 | Vardi et al. | Nov 2005 | B2 |
7018400 | Lashinski et al. | Mar 2006 | B2 |
7056323 | Mareiro et al. | Jun 2006 | B2 |
7060091 | Killion et al. | Jun 2006 | B2 |
20010002443 | Parodi | May 2001 | A1 |
20010002927 | Detampel | Jun 2001 | A1 |
20010002943 | Nagayama et al. | Jun 2001 | A1 |
20010003161 | Vardi et al. | Jun 2001 | A1 |
20010004705 | Killion et al. | Jun 2001 | A1 |
20010004706 | Hojeibane | Jun 2001 | A1 |
20010004707 | Dereume et al. | Jun 2001 | A1 |
20010004823 | Cronin et al. | Jun 2001 | A1 |
20010007954 | Shaolian et al. | Jul 2001 | A1 |
20010012927 | Mauch | Aug 2001 | A1 |
20010016766 | Vardi et al. | Aug 2001 | A1 |
20010016767 | Wilson et al. | Aug 2001 | A1 |
20010016768 | Wilson et al. | Aug 2001 | A1 |
20010020173 | Klumb et al. | Sep 2001 | A1 |
20010020184 | Dehdashtian et al. | Sep 2001 | A1 |
20010025195 | Shaolian et al. | Sep 2001 | A1 |
20010027291 | Shanley | Oct 2001 | A1 |
20010027338 | Greenberg | Oct 2001 | A1 |
20010029396 | Wilson et al. | Oct 2001 | A1 |
20010037116 | Wilson et al. | Nov 2001 | A1 |
20010037138 | Wilson et al. | Nov 2001 | A1 |
20010039448 | Dibie | Nov 2001 | A1 |
20010049552 | Richter et al. | Dec 2001 | A1 |
20010056297 | Hojeibane | Dec 2001 | A1 |
20020013618 | Marotta et al. | Jan 2002 | A1 |
20020013619 | Shanley | Jan 2002 | A1 |
20020022874 | Wilson | Feb 2002 | A1 |
20020026232 | Marotta et al. | Feb 2002 | A1 |
20020035392 | Wilson | Mar 2002 | A1 |
20020042650 | Vardi et al. | Apr 2002 | A1 |
20020052648 | McGuckin, Jr. et al. | May 2002 | A1 |
20020072790 | McGuckin, Jr. et al. | Jun 2002 | A1 |
20020111675 | Wilson | Aug 2002 | A1 |
20020156516 | Vardi et al. | Oct 2002 | A1 |
20020156517 | Perouse | Oct 2002 | A1 |
20020165604 | Shanley | Nov 2002 | A1 |
20020173835 | Bourang et al. | Nov 2002 | A1 |
20020173840 | Brucker et al. | Nov 2002 | A1 |
20020183763 | Callol et al. | Dec 2002 | A1 |
20020193872 | Trout, III et al. | Dec 2002 | A1 |
20020193873 | Brucker | Dec 2002 | A1 |
20030009209 | Hojeibane | Jan 2003 | A1 |
20030028233 | Vardi et al. | Feb 2003 | A1 |
20030050688 | Fischell et al. | Mar 2003 | A1 |
20030055378 | Wang et al. | Mar 2003 | A1 |
20030055483 | Gumm | Mar 2003 | A1 |
20030074047 | Richter | Apr 2003 | A1 |
20030093109 | Mauch | May 2003 | A1 |
20030097169 | Brucker et al. | May 2003 | A1 |
20030114912 | Sequin et al. | Jun 2003 | A1 |
20030125791 | Sequin et al. | Jul 2003 | A1 |
20030125802 | Callol et al. | Jul 2003 | A1 |
20030135259 | Simso | Jul 2003 | A1 |
20030181923 | Vardi | Sep 2003 | A1 |
20030195606 | Davidson | Oct 2003 | A1 |
20040006381 | Sequin et al. | Jan 2004 | A1 |
20040015227 | Vardi et al. | Jan 2004 | A1 |
20040044396 | Clerc et al. | Mar 2004 | A1 |
20040059406 | Cully et al. | Mar 2004 | A1 |
20040088007 | Eidenschink | May 2004 | A1 |
20040117003 | Ouriel et al. | Jun 2004 | A1 |
20040133268 | Davidson et al. | Jul 2004 | A1 |
20040138732 | Suhr et al. | Jul 2004 | A1 |
20040138737 | Davidson | Jul 2004 | A1 |
20040148006 | Davidson et al. | Jul 2004 | A1 |
20040172121 | Eidenschink et al. | Sep 2004 | A1 |
20040186560 | Alt | Sep 2004 | A1 |
20040225345 | Fischell et al. | Nov 2004 | A1 |
20040267352 | Davidson et al. | Dec 2004 | A1 |
20050004656 | Das | Jan 2005 | A1 |
20050010278 | Vardi | Jan 2005 | A1 |
20050015108 | Williams et al. | Jan 2005 | A1 |
20050015135 | Shanley | Jan 2005 | A1 |
20050060027 | Khenansho et al. | Mar 2005 | A1 |
20050096726 | Sequin et al. | May 2005 | A1 |
20050102021 | Osborne | May 2005 | A1 |
20050102023 | Yadin | May 2005 | A1 |
20050119731 | Brucker et al. | Jun 2005 | A1 |
20050125076 | Ginn | Jun 2005 | A1 |
20050131526 | Wong | Jun 2005 | A1 |
20050149161 | Eidenschink et al. | Jul 2005 | A1 |
20050154442 | Eidenschink et al. | Jul 2005 | A1 |
20050154444 | Quadri | Jul 2005 | A1 |
20050183259 | Eidenschink et al. | Aug 2005 | A1 |
20050209673 | Shaked | Sep 2005 | A1 |
20050228483 | Kaplan | Oct 2005 | A1 |
20060036315 | Yadin et al. | Feb 2006 | A1 |
20060041303 | Israel | Feb 2006 | A1 |
20060079956 | Eigler et al. | Apr 2006 | A1 |
20060173528 | Feld et al. | Aug 2006 | A1 |
20070073376 | Krolik et al. | Mar 2007 | A1 |
Number | Date | Country |
---|---|---|
2220864 | Jul 1999 | CA |
9014845 | Feb 1991 | DE |
29701758 | Mar 1997 | DE |
29708803 | Jul 1997 | DE |
0347023 | Dec 1989 | EP |
0479730 | Apr 1992 | EP |
0647148 | Apr 1995 | EP |
0686379 | Dec 1995 | EP |
0804907 | Nov 1997 | EP |
0751752 | Jun 1998 | EP |
0479557 | Jul 1998 | EP |
0876805 | Nov 1998 | EP |
0880949 | Dec 1998 | EP |
0891751 | Jan 1999 | EP |
0895759 | Feb 1999 | EP |
0904745 | Mar 1999 | EP |
0937442 | Aug 1999 | EP |
0783873 | Apr 2000 | EP |
1031328 | Aug 2000 | EP |
1031329 | Aug 2000 | EP |
0883384 | Dec 2000 | EP |
0862392 | Aug 2001 | EP |
0808140 | Dec 2001 | EP |
0884028 | Feb 2002 | EP |
1190685 | Mar 2002 | EP |
0897700 | Jul 2002 | EP |
0684022 | Feb 2004 | EP |
1157674 | Jul 2005 | EP |
1031330 | Nov 2005 | EP |
1070513 | Jun 2006 | EP |
2678508 | Jan 1993 | FR |
2740346 | Apr 1997 | FR |
2756173 | May 1998 | FR |
2760351 | Sep 1998 | FR |
2337002 | Nov 1999 | GB |
8806026 | Aug 1988 | WO |
9219308 | Nov 1992 | WO |
9521592 | Aug 1995 | WO |
9629955 | Oct 1996 | WO |
9634580 | Nov 1996 | WO |
9641592 | Dec 1996 | WO |
9707752 | Mar 1997 | WO |
9715346 | May 1997 | WO |
9716217 | May 1997 | WO |
9726936 | Jul 1997 | WO |
9741803 | Nov 1997 | WO |
9745073 | Dec 1997 | WO |
9746174 | Dec 1997 | WO |
9819628 | May 1998 | WO |
9831306 | Jul 1998 | WO |
9836709 | Aug 1998 | WO |
9837833 | Sep 1998 | WO |
9847446 | Oct 1998 | WO |
9847447 | Oct 1998 | WO |
9848879 | Nov 1998 | WO |
9853759 | Dec 1998 | WO |
9903426 | Jan 1999 | WO |
9904726 | Feb 1999 | WO |
9913808 | Mar 1999 | WO |
9915103 | Apr 1999 | WO |
9915108 | Apr 1999 | WO |
9915109 | Apr 1999 | WO |
9924104 | May 1999 | WO |
9934749 | Jul 1999 | WO |
9936002 | Jul 1999 | WO |
9936015 | Jul 1999 | WO |
9944539 | Sep 1999 | WO |
9956661 | Nov 1999 | WO |
9965419 | Dec 1999 | WO |
0007523 | Feb 2000 | WO |
0010485 | Mar 2000 | WO |
0010489 | Mar 2000 | WO |
0013613 | Mar 2000 | WO |
0016719 | Mar 2000 | WO |
0027307 | May 2000 | WO |
0027463 | May 2000 | WO |
0028922 | May 2000 | WO |
0032266 | Jun 2000 | WO |
0145594 | Jun 2000 | WO |
0044307 | Aug 2000 | WO |
0044309 | Aug 2000 | WO |
0047134 | Aug 2000 | WO |
0048531 | Aug 2000 | WO |
0049951 | Aug 2000 | WO |
0051523 | Sep 2000 | WO |
0057813 | Oct 2000 | WO |
0071054 | Nov 2000 | WO |
0067673 | Nov 2000 | WO |
0071055 | Nov 2000 | WO |
0074595 | Dec 2000 | WO |
0121095 | Mar 2001 | WO |
0121109 | Mar 2001 | WO |
01021244 | Mar 2001 | WO |
0130433 | May 2001 | WO |
0135715 | May 2001 | WO |
0135863 | May 2001 | WO |
0139697 | Jun 2001 | WO |
0139699 | Jun 2001 | WO |
0141677 | Jun 2001 | WO |
0143665 | Jun 2001 | WO |
0143809 | Jun 2001 | WO |
0145785 | Jun 2001 | WO |
0149342 | Jul 2001 | WO |
0154621 | Aug 2001 | WO |
0154622 | Aug 2001 | WO |
0158385 | Aug 2001 | WO |
0160284 | Aug 2001 | WO |
0170294 | Sep 2001 | WO |
0170299 | Sep 2001 | WO |
0174273 | Oct 2001 | WO |
0189409 | Nov 2001 | WO |
0200138 | Jan 2002 | WO |
02053066 | Jul 2002 | WO |
02068012 | Sep 2002 | WO |
03007842 | Jan 2003 | WO |
03055414 | Jul 2003 | WO |
03063924 | Aug 2003 | WO |
2004026174 | Apr 2004 | WO |
2004026180 | Apr 2004 | WO |
2005009295 | Feb 2005 | WO |
2005014077 | Feb 2005 | WO |
2006028925 | Mar 2006 | WO |
Entry |
---|
Chevalier, M.D., Bernard, “Placement of Coronary Stents in Bifurcation Lesions by the “Culotte” Technique,” The American Journal of Cardiology, vol. 82, pp. 943-949 (Oct. 15, 1998). |
Nakamura M.D., Shigeru, “Techniques for Palmaz-Schatz Stent Deployment in Lesions with a Large Side Branch,” Catheterization and Cardiovascular Diagnosis, vol. 34, pp. 353-361 (1995). |
Caputo, Ronald P., “Stent Jail: A Minimum-Security Prison,” The American Journal of Cardiology, vol. 77, pp. 1226-1230 (Jun. 1, 1996). |
Colombo, M.D., Antonio, ““Kissing” Stent for Bifurcational Coronary Lesion,” Catheterization and Cardiovascular Diagnosis, vol. 30, pp. 327-330 (Dec. 1993). |
Carrie, M.D., Didier, ““T”-Shaped Stent Placement: A Technique for the Treatment of Dissected Bifurcation Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 37, pp. 311-313 (Mar. 1996). |
Katoh, M.D., Osamu, “New Double Wire Technique to Stent Ostial Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 40, pp. 400-402 (Apr. 1997). |
Lewis, M.D., Bruce E., “Acute procedural results in the treatment of 30 coronary artery bifurcation lesions with a double-wire atherectomy technique for side-branch protection,” American Heart Journal, vol. 127:6, pp. 1600-1607 (Jun. 1994). |
Yamashita, M.D.,PhD., Takehiro, “Bifurcation Lesions: Two Stents Versus One Stent—Immediate and Follow-up Results,” Journal of the American College of Cardiology, vol. 35:5, pp. 1145-1151 (Apr. 2000). |
Satler, M.D., Lowell F., “Bifurcation Disease: To Treat or Not to Treat,” Catheterization and Cardiovascular Interventions, vol. 50, pp. 411-412 (2000). |
U.S. Appl. No. 9/325,996, filed Jun. 4, 1999, Vardi et al. |
U.S. Appl. No. 9/614,472, filed Jul. 11, 2000, Davidson et al. |
U.S. Appl. No. 9/663,111, filed Sep. 15, 2000, Davidson et al. |
TRIO™ 14 PTCA Catheter, Re-engineering Over the Wire Balloon Technology, Company Brochure Copyright 1994. |
Number | Date | Country | |
---|---|---|---|
20070135904 A1 | Jun 2007 | US |